BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31043813)

  • 1. Estimating the health care costs of non-melanoma skin cancer in Saskatchewan using physician billing data.
    Tran DA; Coronado AC; Sarker S; Alvi R
    Curr Oncol; 2019 Apr; 26(2):114-118. PubMed ID: 31043813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician specialty cost differences of treating nonmelanoma skin cancer.
    Chirikov VV; Stuart B; Zuckerman IH; Christy MR
    Ann Plast Surg; 2015 Jan; 74(1):93-9. PubMed ID: 24503881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of nonmelanoma skin cancer treatment in the United States.
    Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
    Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
    Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin cancer healthcare impact: A nation-wide assessment of an administrative database.
    Duarte AF; Sousa-Pinto B; Freitas A; Delgado L; Costa-Pereira A; Correia O
    Cancer Epidemiol; 2018 Oct; 56():154-160. PubMed ID: 30179829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of non-melanoma skin cancer: a review.
    Mudigonda T; Pearce DJ; Yentzer BA; Williford P; Feldman SR
    J Natl Compr Canc Netw; 2010 Aug; 8(8):888-96. PubMed ID: 20870635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health economic evaluation of non-melanoma skin cancer and actinic keratosis.
    Higashi MK; Veenstra DL; Langley PC
    Pharmacoeconomics; 2004; 22(2):83-94. PubMed ID: 14731050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.
    Pohar SL; Majumdar SR; Johnson JA
    Clin Ther; 2007; 29 Spec No():1316-24. PubMed ID: 18046931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
    Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
    J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Financial Integration Between Physicians and Hospitals With Commercial Health Care Prices.
    Neprash HT; Chernew ME; Hicks AL; Gibson T; McWilliams JM
    JAMA Intern Med; 2015 Dec; 175(12):1932-9. PubMed ID: 26501217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-melanoma skin cancer in Australia.
    Fransen M; Karahalios A; Sharma N; English DR; Giles GG; Sinclair RD
    Med J Aust; 2012 Nov; 197(10):565-8. PubMed ID: 23163687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare Service Utilization for Practicing Physicians: A Population-Based Study.
    Chiu YL; Kao S; Lin HC; Tsai MC; Lee CZ
    PLoS One; 2016; 11(1):e0130690. PubMed ID: 26752592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care costs and mortality for Canadian urban and rural patients with diabetes: population-based trends from 1993-2001.
    Pohar SL; Majumdar SR; Johnson JA
    Clin Ther; 2007 Jun; 29(6 Pt 1):1316-24. PubMed ID: 18036393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment patterns and cost of nonmelanoma skin cancer management.
    John Chen G; Yelverton CB; Polisetty SS; Housman TS; Williford PM; Teuschler HV; Feldman SR
    Dermatol Surg; 2006 Oct; 32(10):1266-71. PubMed ID: 17034377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.
    Joseph AK; Mark TL; Mueller C
    Dermatol Surg; 2001 Nov; 27(11):955-9. PubMed ID: 11737130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
    Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
    J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic burden of occupational non-melanoma skin cancer due to solar radiation.
    Mofidi A; Tompa E; Spencer J; Kalcevich C; Peters CE; Kim J; Song C; Mortazavi SB; Demers PA
    J Occup Environ Hyg; 2018 Jun; 15(6):481-491. PubMed ID: 29695213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary Practice.
    Dharnidharka VR; Naik AS; Axelrod D; Schnitzler MA; Xiao H; Brennan DC; Segev DL; Randall H; Chen J; Kasiske B; Lentine KL
    Transplantation; 2017 Apr; 101(4):858-866. PubMed ID: 27490413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.